tirzepatide novo nordisk CEO Mike Doustdar spoke with CNBC's Charlotte Reed about strong demand for its weight-loss drugs and a surge in new patients. 🔗Tap the link in bio to read more Eli Lilly's Weight-Loss Drug is

(1989) Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

It is important to note that GLP-1 receptor agonists, including semaglutide, are associated with an increased risk of gallbladder disease (such as gallstones), which can sometimes present with symptoms resembling liver problems, including jaundice or abnormal liver function tests

Individuals taking Mounjaro should seek immediate medical attention if blood clot symptoms are detected, such as leg swelling, pain, tenderness, or redness

A healthcare provider can help identify ways to manage common side effects or may recommend a different medication

Evening routine 13